SCHEMBL7301661

SCHEMBL7301661

CC(C)[C@H](N)C(=O)Nc1nc2ccccc2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.62
FFAR2 O15552 1/20 0.62
CYP3A4 P08684 1/20 0.62
RAB9A P51151 7/20 0.56
NPC1 O15118 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
HTT P42858 2/20 0.56
HSD17B10 Q99714 1/20 0.56
PKM P14618 2/20 0.56
MAOB P27338 1/20 0.56
ADORA2A P29274 1/20 0.56
XIAP P98170 1/20 0.55
ALPL P05186 1/20 0.55
ALPI P09923 1/20 0.55
ALPG P10696 1/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 2/20 0.55
MITF O75030 1/20 0.55
KLF5 Q13887 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106998 0.85 LMNA (0.69) LMNAFFAR2CYP3A4RAB9ANPC1
SCHEMBL1121189 0.81 HSD17B10 (0.66) LMNAFFAR2CYP3A4RAB9ANPC1
SCHEMBL11578322 0.79 HSD17B10 (0.67) LMNAFFAR2CYP3A4RAB9ANPC1
Benzene SCHEMBL7282826 0.78 NPC1 (0.60) LMNAFFAR2CYP3A4RAB9ANPC1
SCHEMBL30968980 0.77 LMNA (1.00) LMNACYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL29776932 0.77 CYP3A4 (1.00) LMNACYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL707208 0.77 CYP3A4 (1.00) LMNACYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL1434166 0.77 LMNA (1.00) LMNACYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL23566380 0.77 NPC1 (0.75) LMNACYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL4236216 0.77 CYP3A4 (0.65) LMNAFFAR2CYP3A4RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP claimed
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP disclosed